MMP-2 and MMP-9 expression in adult and childhood acute lymphatic leukemia (ALL)

Leukemia Research

Volumn 25, Issue 2, 2001, Pages 125-131

  Kuittinen, Outi ^a   Savolainen, Eeva Riitta ^a   Koistinen, Pirjo ^a   Möttönen, Merja ^a   Turpeenniemi Hujanen, Taina ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Acute lymphocytic leukemia; Invasion; MMP 2; MMP 9; Prognosis; Prognostic factors

Indexed keywords

GELATINASE A; GELATINASE B;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; CHILD; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED;

EID: 0035137223     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00104-1     Document Type: Article

References (23)

1. Proteolytic remodeling of extracellular matrix
2. T cell gelatinases mediate basement membrane transmigration in vitro
3. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor Batimastat (BB-94)
4. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
5. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma
6. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
7. Matrix metalloproteinase-2 immunoreactive protein a marker of aggressiveness in breast carsinoma
8. Ession of matrix metalloproteinases (MMP-2 and -9) and tissue Inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells
9. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia and myelodysplastic syndromes
10. Gelatinase A and B (MMP-2, MMP-9) in Leukaemia MMP-2 may indicate a good prognosis in AML
11. Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice
12. Proposals for the classification of the acute leukaemias
13. Intensified treatment of acute childhood lymphoblastic leukemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996
14. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoksidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures
15. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase as a marker of terminal neutrophil differentiation
16. Unstimulated human acute myelogenous leukemia blasts secrete matrixmetalloproteinases
17. Tumor necrosis alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion
18. Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
19. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD 34+ cells and their transmigration through reconstituted basement membrane
20. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2)